CHANGE IN RATINGS

Alliant Techsystems ( ATK) downgraded at Goldman Sachs to Sell from Neutral due to high valuation, mediocre fundamentals and lack of potential catalysts. Note that shares trade at a substantial premium to Defense peers despite growth that is likely to be in-line with group. See limited potential for improved guidance during next earnings report. Price target cut to $56 from $73.

Beckman Coulter ( BEC) upgraded at Barclays from Equal-weight to Overweight. $55 price target. Company's recurring revenue model provides both stability and visibility.

Eaton Vance ( EV) downgraded at Goldman Sachs to Neutral from Buy due to decelerating organic growth and lagging performance in large cap value funds. Note ongoing pressure in asset management industry and expect poor Q1 results across sector. Price target lowered to $18 from $20.

Life Technologies ( LIFE) upgraded at Morgan Stanley from Equal-weight to Overweight. $37 price target. Guidance has been set at a reasonable level, and the company should be able to realize cost synergies over the coming quarters.

M&T Bank ( MTB) downgraded at Citigroup from Buy to Hold. $40 price target. Estimates also cut, to reflect the weaker economy and lower credit quality.

Knight Capital ( NITE) downgraded at Goldman Sachs to Neutral from Buy due to headwinds for quantitative trading models, higher Section 31 fees and potential reinstatement of uptick rule. Quant models were some of the worst performers during February and March, likely hurting a key driver for company's market making business. Price target lowered to $17 from $20.

Terex ( TEX) downgraded at Wachovia from Outperform to Market Perform. Valuation call. Estimates also cut to reflect lower sales expectations.

Waddell & Reed ( WDR) upgraded at Goldman Sachs to Buy from Neutral. Relative and absolute performance for company's funds improved during the first quarter. Also note potential to capture further retail share in asset management space. Price target raised to $18 from $12.

STOCK COMMENTS / EPS CHANGES

Baxter ( BAX) estimates, target reduced at UBS to $60 a share. Estimates also reduced to reflect a higher realized tax rate. Buy rating.

Cintas ( CTAS) estimates lowered through 2010, target cut at Barclays Capital. Falling revenues will hurt margins. Equal-weight rating and new $23 price target.

Darden Restaurants ( DRI) estimates increased through 2010, target raised at UBS. Company has had decent sales trends and costs are down. Neutral rating and new $38 price target.

Eastman Chemical ( EMN) 2009 estimate increased at Barclays because of cost-cutting efforts. Equal-weight rating and new $26 price target.

General Mills ( GIS) numbers reduced at Barclays to $56. 2009 estimates also cut, to reflect currency and pension headwinds. Overweight rating.

McDonald's ( MCD) estimates lowered at UBS through 2010. Company is being hurt by the currency drag. Buy rating and $63 price target.

McDermott ( MDR) 2009 estimate raised because of recent awards, target increased at UBS. Company has a lower risk profile. Buy rating and new $17 price target.

Marvell Technology ( MRVL) 2011 estimates cut at Morgan Stanley because of possible market share losses. Equal-weight rating.

Monster Worldwide ( MWW) numbers lowered at UBS cut through 2010. Labor market continues to deteriorate. Neutral rating and new $9 price target.

Netflix ( NFLX) 2009 estimate increased because of higher subscription numbers, target raised at Barclays Capital. Overweight rating and new $48 price target.

Oracle ( ORCL) estimates raised through 2010, target increased at UBS. Company is seeing better license performance and generates strong cash flow. Buy rating and new $20 price target.

Oracle ( ORCL) estimates raised at Barclays through 2010. Company will likely continue to gain market share in the coming quarters, boosting margins. Overweight rating and $21 price target.
This article was written by a staff member of TheStreet.com.